Skip to content

Comment on BioNTech CEO applies Covid-19 vaccine's mRNA tech to multiple sclerosisparent

Comments

The have to go through an approval process on every update but AFAICR only with a study including 300 adults, so substantially less then the tens of thousands that were included in the Biontec/Moderna trails.

Thanks. So they only test for lack of side effects, not for effectivity (outside of leech dish experiments), because with just 300 it would take decades to see a meaningful delta? (unless they do challenge tests?)

You think the mRNA vaccines with minimal changes be treated similarly? e.g one years flu cocktail, vs the next?

AboutSource Built by g1lg1l

Hackerly is an independent reader for Hacker News, built on the public HN API. Not affiliated with Y Combinator.